Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
TB-500 has been through Phase I and Phase II clinical trials of intravenous thymosin beta-4 with no serious adverse events reported in the published cohorts
KEY HIGHLIGHTS: Reduces the appearance of unwanted spots
Pharmacology offers parallels
This preparation is intended for research use in biochemical and pharmacological model systems.Not for human use
Researchers have identified certain features of these studies that can produce false-positive outcomes
When B12 levels fall, nerves can become damaged or struggle to function correctly which may lead to neuropathic symptoms
US$ 26.95
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
US$ 26.72
US$ 27.59
,type=downsize)
![Omanyte (17/124) [XY: Fates Collide] H17](https://cdn.shopify.com/s/files/1/0824/7345/1830/files/105454cf-a6b9-4737-9da9-929ef8d5f35f.png?v=1740083330)
![Umbreon (10/90) (Theme Deck Exclusive) [HeartGold & SoulSilver: Undaunted] SV13](https://cdn.shopify.com/s/files/1/0824/7345/1830/products/c8447073-502d-49c9-83aa-333c7931fc1d.jpg?v=1697571271)
